解读PSMB9在黑色素瘤中的瘤抑制作用,通过多细胞和单细胞转录组分析
Xing Hu1, Zhengang Hu2, Hao Zhang3
1Department of Dermatology, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan, 410000, China.
Cancer letters
|November 9, 2023
概括
这项研究确定了一种对干扰素- (IFN-g) 敏感的新型黑色素瘤亚型,显示出更好的结果和免疫细胞透. PSMB9基因是预测免疫治疗反应的关键标志物,可能抑制黑色素瘤生长.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 皮肤皮肤黑色素瘤 (SKCM) 是一种主要的皮肤癌挑战.
- 免疫疗法已经推进了黑色素瘤治疗,但瘤异质性仍然是一个问题.
- 表观遗传修饰,如DNA甲基化,影响黑色素瘤的发展和预后.
研究的目的:
- 为了确定一个干扰素- (IFN-g) 敏感的黑色素瘤亚型,具有有利的结果.
- 开发基于机器学习的IFN-g灵敏性签名.
- 研究PSMB9作为黑色素瘤免疫治疗的预后和预测标记物的作用.
主要方法:
- 在患者组织上进行批量和单细胞RNA测序 (RNA-seq).
- 机器学习用于签名开发.
- 基因表达和甲基化分析.
- 在SKCM细胞系中过度表达PSMB9.
主要成果:
- 鉴定出一种IFN-g敏感亚型,其特征是良好的结果,CD8+ T细胞透和高IFN-g得分.
- 建立了一个10探针的IFN-g敏感性特征,PSMB9与免疫治疗反应有很强的相关性.
- 在SKCM细胞系中PSMB9的过度表达抑制了细胞的增殖和迁移,这表明PSMB9有抑制瘤的作用.
- 单细胞RNA-seq揭示了PSMB9在激活CD8+T细胞和影响恶性细胞受体方面的作用.
结论:
- PSMB9是黑色素瘤的关键预后标志物,具有免疫治疗反应的预测潜力.
- PSMB9对恶性和免疫细胞都有影响,突出显示了其多方面的作用.
- PSMB9代表了未来黑色素瘤免疫治疗策略的潜在治疗标.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


